Mustang Bio, Inc. (MBIO): Hedge Funds In Wait-and-See Mode
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Mustang Bio Inc. (MBIO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 3,606,543 | $638,358 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 87,500 | $15,488 | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.52 | 5,000 | Director | 1,098,987 | 2022-09-13 | Filing | |
| $0.74 | 5,000 | Director | 1,032,987 | 2022-03-18 | Filing | |
| $0.52 | 5,000 | Director | 299,181 | 2022-09-13 | Filing | |
| $0.74 | 4,094 | Director | 222,517 | 2022-03-18 | Filing | |
| $2.24 | 65,000 | Officer, Director | 1,027,987 | 2021-10-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.83 | 4,374 | Officer | 144,729 | 2021-12-14 | Filing | |
| $2.28 | 4,450 | Officer | 126,603 | 2021-10-12 | Filing | |
| $3.04 | 8,348 | Officer, Director | 813,035 | 2020-05-22 | Filing | |
| $3.04 | 4,025 | Officer, Director | 821,383 | 2020-05-22 | Filing | |
| $3.36 | 2,423 | Officer | 131,053 | 2021-04-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
15 Best Penny Stocks to Buy Now
Many novice investors are bullish on penny stocks with growth potential for capital appreciation. All iconic stocks were once penny stocks.
Hedge Fund and Insider Trading News: Whitebox Advisors, Gammon Capital, Fenician Capital Management, BNP Paribas Asset Management, GW Pharmaceuticals PLC (GWPH), Mustang Bio Inc (MBIO), and More
A New York hedge fund that’s gained 449% in this year’s pandemic roller-coaster is betting on a new wave of volatility in the event Congress fails to extend a key bank provision in any new stimulus...
Hedge Funds Have Never Been This Bullish On Mustang Bio, Inc. (MBIO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Done Buying Mustang Bio, Inc. (MBIO)
A whopping number of 13F filings filed with U.S.
Billionaire Hedge Funds
